Sara Signa
- Nephrology top 10%
-
- Immunodeficiency and Autoimmune Disorders 6
- Psoriasis: Treatment and Pathogenesis 2
-
- Adenosine and Purinergic Signaling 3
-
- Autoimmune and Inflammatory Disorders Research 2
-
- Long-Term Effects of COVID-19 3
-
- Urticaria and Related Conditions 2
-
- COVID-19 Clinical Research Studies 2
-
- Cerebral Palsy and Movement Disorders 2
- Co-authors
- Marco GattornoRoberta CaorsiStefano VolpiIsabella CeccheriniFrancesca SchenaElisa TassanoGiorgio GimelliMaja Di Rocco
- Cited by
- NephrologyImmunologyPhysiology
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Sara Signa
23 papers receiving 285 citations
Peers
Comparison fields: 5 of 53
- Nephrology 41
- Immunology 107
- Physiology 17
- Hematology 32
- Neurology 42
Countries citing papers authored by Sara Signa
This map shows the geographic impact of Sara Signa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Signa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Signa more than expected).
Fields of papers citing papers by Sara Signa
This network shows the impact of papers produced by Sara Signa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Signa. The network helps show where Sara Signa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sara Signa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 0 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 26 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 0 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 18 | |
| 16 | 2020 | 4 | |
| 17 | 2019 | 23 | |
| 18 | 2016 | 24 | |
| 19 | 2015 | 1 | |
| 20 | 2013 | 18 |
About Sara Signa
Sara Signa is a scholar working on Physiology, Immunology and Neurology, having authored 28 papers that have together received 288 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (6 papers), Adenosine and Purinergic Signaling (3 papers), Long-Term Effects of COVID-19 (3 papers), Urticaria and Related Conditions (2 papers), COVID-19 Clinical Research Studies (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Cerebral Palsy and Movement Disorders (2 papers). The work is most often cited by research in Nephrology (41 citations), Immunology (107 citations) and Physiology (17 citations). Sara Signa has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Marco Gattorno, Roberta Caorsi, Stefano Volpi, Isabella Ceccherini, Francesca Schena, Elisa Tassano, Giorgio Gimelli, Maja Di Rocco, Federica Penco and Alice Grossi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.